OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UF Health Shands Hospital, Gainesville, Florida, United States
Contact: Study coordinator (Victoria Hope) · victoria.hope@neurosurgery.ufl.edu · 352-273-9000
Contact: Principal Investigator (Ashley Ghiaseddin, MD)

Study leads

Ashley Ghiaseddin, MD
Principal Investigator
University of Florida

View source on ClinicalTrials.gov Contact study team (email)